Loading clinical trials...
Loading clinical trials...
A Study to Assess Midline Frontal Theta (MFT) Power as Measured by Stimulus-locked Electroencephalography (EEG) Before and After AKL-T01 Treatment for Improving Attention in Pediatric Participants Ages 8-12 Years Old With Attention Deficit Hyperactivity Disorder (ADHD)
Conditions
Interventions
AKL-T01
Locations
1
United States
Cortica Healthcare
San Rafael, California, United States
Start Date
May 10, 2019
Primary Completion Date
February 1, 2020
Completion Date
February 1, 2020
Last Updated
November 14, 2023
NCT07189442
NCT06123741
NCT06847165
NCT04175041
NCT07459699
NCT07439276
Lead Sponsor
Akili Interactive Labs, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions